Announcements Trials
Browse Landscape

Phase

Phase 2 89Phase 1 60Phase NA 41Phase 1/2 26Phase 3 13Phase EARLY_PHASE1 11Phase 4 3

Status

Completed 21Recruiting 4Unknown 3Terminated 3Withdrawn 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Fluoresceins 1Fluorescein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Brain Neoplasms × Clear all
NCT02028325 2016-11-08

Fluorescein

Indiana University

Phase 4 Terminated
136 enrolled 4 charts
CNS

Brain Neoplasms

NCT01756729 2016-03-02

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

NovoCure Ltd.

Phase 4 Terminated
13 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

NCT00415467 2012-08-02

Treatment of Resectable Malignant Brain Tumors

M.D. Anderson Cancer Center

Phase 4 Terminated
13 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡